HSD17B7
3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7
Also known as: DHB7_HUMAN, PRAP, SDR37C1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56937
- Gene
- HSD17B7
- Ensembl
- ENSG00000132196
- Chromosome
- 1
- Canonical length
- 341 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
HSD17B7 encodes an enzyme that functions both as a 17-beta-hydroxysteroid dehydrogenase (EC 1.1.1.62) in the biosynthesis of sex steroids and as a 3-ketosteroid reductase (EC 1.1.1.270) in the biosynthesis of cholesterol (Marijanovic et al., 2003 [PubMed 12829805]).[supplied by OMIM, May 2010]
Canonical amino-acid sequenceUniProt
341 residues, UniProt reviewed canonical sequence.
>P56937|HSD17B7
1 MRKVVLITGA SSGIGLALCK RLLAEDDELH LCLACRNMSK AEAVCAALLA SHPTAEVTIV
61 QVDVSNLQSV FRASKELKQR FQRLDCIYLN AGIMPNPQLN IKALFFGLFS RKVIHMFSTA
121 EGLLTQGDKI TADGLQEVFE TNVFGHFILI RELEPLLCHS DNPSQLIWTS SRSARKSNFS
181 LEDFQHSKGK EPYSSSKYAT DLLSVALNRN FNQQGLYSNV ACPGTALTNL TYGILPPFIW
241 TLLMPAILLL RFFANAFTLT PYNGTEALVW LFHQKPESLN PLIKYLSATT GFGRNYIMTQ
301 KMDLDEDTAE KFYQKLLELE KHIRVTIQKT DNQARLSGSC LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HSD17B7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- liver: 65 nTPM
- adrenal gland: 26 nTPM
- pituitary gland: 15 nTPM
- choroid plexus: 14 nTPM
- spinal cord: 13 nTPM
- esophagus: 13 nTPM
Single-cell type
- epididymal principal cells: 247 nCPM
- epididymal efferent duct ciliated cells: 105 nCPM
- breast lactating cells: 87 nCPM
- adrenal cortex cells: 55 nCPM
- alveolar cells type 2: 43 nCPM
- epididymal efferent duct absorptive cells: 39 nCPM
Immune cell
- basophil: 24 nTPM
- T-reg: 18 nTPM
- MAIT T-cell: 15 nTPM
- memory CD8 T-cell: 14 nTPM
- gdT-cell: 14 nTPM
- naive CD4 T-cell: 13 nTPM
Brain region
- midbrain: 12 nTPM
- pons: 12 nTPM
- medulla oblongata: 11 nTPM
- white matter: 11 nTPM
- hypothalamus: 11 nTPM
- cerebral cortex: 10 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.59
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- androgen metabolic process
- brain development
- cell differentiation
- cholesterol biosynthetic process
- cholesterol biosynthetic process via lathosterol
- embryonic organ development
- embryonic skeletal system development
- estrogen biosynthetic process
Molecular functions
- 3-beta-hydroxysteroid 3-dehydrogenase (NADP+) activity
- 5-alpha-androstane-3-beta,17-beta-diol dehydrogenase (NADP+) activity
- estradiol 17-beta-dehydrogenase [NAD(P)+] activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Short-chain dehydrogenase/reductase SDR
- NAD(P)-binding domain superfamily
- short chain dehydrogenase
- 3-keto-steroid reductase
- 3-Keto-Steroid Reductase/17-beta-Hydroxysteroid Dehydrogenase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HSD17B7 as an antibody target. Whether an autoantibody or antibody against HSD17B7 could matter depends on whether native HSD17B7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HSD17B7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HSD17B7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...